Similar articles for PMID: 25952734

Year	Number of Results
1990	1
1991	2
1992	1
1993	3
1995	2
1996	3
1998	1
2001	1
2003	1
2004	1
2005	1
2006	3
2008	2
2009	3
2010	1
2011	2
2012	1
2013	1
2014	5
2015	6
2016	8
2017	10
2018	13
2019	7
2020	9
2021	13
2022	19
2023	6
2024	0

1

Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies.

Tavaré R, McCracken MN, Zettlitz KA, Salazar FB, Olafsen T, Witte ON, Wu AM. Tavaré R, et al. J Nucl Med. 2015 Aug;56(8):1258-64. doi: 10.2967/jnumed.114.153338. Epub 2015 May 7. J Nucl Med. 2015. PMID: 25952734 Free PMC article.

2

CD4⁺ and CD8a⁺ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models.

Kristensen LK, Fröhlich C, Christensen C, Melander MC, Poulsen TT, Galler GR, Lantto J, Horak ID, Kragh M, Nielsen CH, Kjaer A. Kristensen LK, et al. Theranostics. 2019 Oct 18;9(26):8221-8238. doi: 10.7150/thno.37513. eCollection 2019. Theranostics. 2019. PMID: 31754392 Free PMC article.

3

Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.

Beckford Vera DR, Smith CC, Bixby LM, Glatt DM, Dunn SS, Saito R, Kim WY, Serody JS, Vincent BG, Parrott MC. Beckford Vera DR, et al. PLoS One. 2018 Mar 7;13(3):e0193832. doi: 10.1371/journal.pone.0193832. eCollection 2018. PLoS One. 2018. PMID: 29513764 Free PMC article.

4

An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.

Tavaré R, Escuin-Ordinas H, Mok S, McCracken MN, Zettlitz KA, Salazar FB, Witte ON, Ribas A, Wu AM. Tavaré R, et al. Cancer Res. 2016 Jan 1;76(1):73-82. doi: 10.1158/0008-5472.CAN-15-1707. Epub 2015 Nov 16. Cancer Res. 2016. PMID: 26573799 Free PMC article.

5

ImmunoPET Imaging of Murine CD4⁺ T Cells Using Anti-CD4 Cys-Diabody: Effects of Protein Dose on T Cell Function and Imaging.

Freise AC, Zettlitz KA, Salazar FB, Lu X, Tavaré R, Wu AM. Freise AC, et al. Mol Imaging Biol. 2017 Aug;19(4):599-609. doi: 10.1007/s11307-016-1032-z. Mol Imaging Biol. 2017. PMID: 27966069 Free PMC article.

6

Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.

Tavaré R, McCracken MN, Zettlitz KA, Knowles SM, Salazar FB, Olafsen T, Witte ON, Wu AM. Tavaré R, et al. Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1108-13. doi: 10.1073/pnas.1316922111. Epub 2014 Jan 3. Proc Natl Acad Sci U S A. 2014. PMID: 24390540 Free PMC article.

7

Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis.

Freise AC, Zettlitz KA, Salazar FB, Tavaré R, Tsai WK, Chatziioannou AF, Rozengurt N, Braun J, Wu AM. Freise AC, et al. J Nucl Med. 2018 Jun;59(6):980-985. doi: 10.2967/jnumed.117.199075. Epub 2018 Jan 11. J Nucl Med. 2018. PMID: 29326360 Free PMC article.

8

Preclinical development of ZED8, an ⁸⁹Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.

Ogasawara A, Kiefer JR, Gill H, Chiang E, Sriraman S, Ferl GZ, Ziai J, Bohorquez SS, Guelman S, Wang X, Yang J, Phan MM, Nguyen V, Chung S, Yu C, Tinianow J, Waaijer SJH, De Crespigny A, Marik J, Boswell CA, Zabka T, Staflin K, Williams SP. Ogasawara A, et al. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):287-301. doi: 10.1007/s00259-022-05968-6. Epub 2022 Oct 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 36271158

9

CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of ⁸⁹Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody.

Farwell MD, Gamache RF, Babazada H, Hellmann MD, Harding JJ, Korn R, Mascioni A, Le W, Wilson I, Gordon MS, Wu AM, Ulaner GA, Wolchok JD, Postow MA, Pandit-Taskar N. Farwell MD, et al. J Nucl Med. 2022 May;63(5):720-726. doi: 10.2967/jnumed.121.262485. Epub 2021 Aug 19. J Nucl Med. 2022. PMID: 34413145 Free PMC article. Clinical Trial.

10

Development of ⁸⁹Zr-anti-CD103 PET imaging for non-invasive assessment of cancer reactive T cell infiltration.

Kol A, Fan X, Wazynska MA, van Duijnhoven SMJ, Giesen D, Plat A, Van Eenennaam H, Elsinga PH, Nijman HW, de Bruyn M. Kol A, et al. J Immunother Cancer. 2022 Dec;10(12):e004877. doi: 10.1136/jitc-2022-004877. J Immunother Cancer. 2022. PMID: 36600560 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

107 results

Results by year